Dr Padmaja Kolachana, MD | |
8316 Arlington Blvd, Suite 104, Fairfax, VA 22031-5207 | |
(703) 560-1313 | |
(703) 876-0824 |
Full Name | Dr Padmaja Kolachana |
---|---|
Gender | Female |
Speciality | Hospitalist |
Experience | 32 Years |
Location | 8316 Arlington Blvd, Fairfax, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316979305 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 0101056555 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fairfax Dialysis Center | Fairfax, VA | Dialysis facility |
Virginia Hospital Center | Arlington, VA | Hospital |
Inova Fairfax Hospital | Falls church, VA | Hospital |
Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fair Oaks Hospitalist Physicians, Pllc | 1052419868 | 40 |
Washington Nephrology Associates Llp | 8527951318 | 26 |
Washington Nephrology Associates Llp | 8527951318 | 26 |
News Archive
Eisai Inc. today announces that it has entered into a licensing agreement with the Johns Hopkins University's Brain Science Institute related to Eisai's GCPII (glutamate carboxypeptidase II) technology.
Sleep disturbance is common for many women during menopause, creating an array of adverse health outcomes such as heart disease, hypertension, and depression.
Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the Federal Food, Drug, and Cosmetic Act related to safety problems with some of its implantable defibrillators. Guidant LLC formerly did business as Guidant Corporation. The Justice Department filed the criminal information today in connection with an agreement with Guidant to resolve the charges. A formal guilty plea agreement is expected to be filed with the court at a later date.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.
› Verified 4 days ago
Entity Name | Washington Nephrology Associates Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124193479 PECOS PAC ID: 8527951318 Enrollment ID: O20040610001168 |
News Archive
Eisai Inc. today announces that it has entered into a licensing agreement with the Johns Hopkins University's Brain Science Institute related to Eisai's GCPII (glutamate carboxypeptidase II) technology.
Sleep disturbance is common for many women during menopause, creating an array of adverse health outcomes such as heart disease, hypertension, and depression.
Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the Federal Food, Drug, and Cosmetic Act related to safety problems with some of its implantable defibrillators. Guidant LLC formerly did business as Guidant Corporation. The Justice Department filed the criminal information today in connection with an agreement with Guidant to resolve the charges. A formal guilty plea agreement is expected to be filed with the court at a later date.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.
› Verified 4 days ago
Entity Name | Fair Oaks Hospitalist Physicians, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275601205 PECOS PAC ID: 1052419868 Enrollment ID: O20070601000279 |
News Archive
Eisai Inc. today announces that it has entered into a licensing agreement with the Johns Hopkins University's Brain Science Institute related to Eisai's GCPII (glutamate carboxypeptidase II) technology.
Sleep disturbance is common for many women during menopause, creating an array of adverse health outcomes such as heart disease, hypertension, and depression.
Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the Federal Food, Drug, and Cosmetic Act related to safety problems with some of its implantable defibrillators. Guidant LLC formerly did business as Guidant Corporation. The Justice Department filed the criminal information today in connection with an agreement with Guidant to resolve the charges. A formal guilty plea agreement is expected to be filed with the court at a later date.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Padmaja Kolachana, MD 4915 Auburn Ave, Suite 200, Bethesda, MD 20814-2636 Ph: (301) 907-3939 | Dr Padmaja Kolachana, MD 8316 Arlington Blvd, Suite 104, Fairfax, VA 22031-5207 Ph: (703) 560-1313 |
News Archive
Eisai Inc. today announces that it has entered into a licensing agreement with the Johns Hopkins University's Brain Science Institute related to Eisai's GCPII (glutamate carboxypeptidase II) technology.
Sleep disturbance is common for many women during menopause, creating an array of adverse health outcomes such as heart disease, hypertension, and depression.
Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the Federal Food, Drug, and Cosmetic Act related to safety problems with some of its implantable defibrillators. Guidant LLC formerly did business as Guidant Corporation. The Justice Department filed the criminal information today in connection with an agreement with Guidant to resolve the charges. A formal guilty plea agreement is expected to be filed with the court at a later date.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
A dome-shaped macula appears to result from the relative thickening of the central macular sclera, researchers have found.
› Verified 4 days ago
Shivangi Vachhani, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3700 Joseph Siewick Dr Ste 408a, Fairfax, VA 22033 Phone: 877-511-4625 Fax: 703-204-9006 | |
Dr. Raymund S Cuevo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-0241 | |
Dr. Michael Maitland, M.D., PH.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-1601 | |
Dr. Paul G. Rochmis, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3027 Javier Rd, Suite 2, Fairfax, VA 22031 Phone: 703-573-2220 Fax: 703-573-7767 | |
Aswani Kumar Suthrave, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3600 | |
Nader H Balba, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3028 Javier Rd Ste 500, Fairfax, VA 22031 Phone: 703-698-8960 Fax: 571-494-5794 | |
Rona Harthill Earle, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3020 Hamaker Ct Ste B102, Fairfax, VA 22031 Phone: 703-573-4072 Fax: 703-572-2153 |